Zeuthen J - Search Results

1

T-cell receptor v-alpha and v-Beta gene usage in interleukin-2-cultured tumor-infiltrating lymphocytes from patients with breast-cancer.

Andersen E, Scholler J, Straten P, Duun S, Zeuthen J. Andersen E, et al. Among authors: zeuthen j. Int J Oncol. 1994 May;4(5):1035-41. doi: 10.3892/ijo.4.5.1035. Int J Oncol. 1994. PMID: 21567016

2

Preferential usage of T-cell receptor alpha beta variable regions among tumor-infiltrating lymphocytes in primary human malignant melanomas.

Thor Straten P, Schøller J, Hou-Jensen K, Zeuthen J. Thor Straten P, et al. Among authors: zeuthen j. Int J Cancer. 1994 Jan 2;56(1):78-86. doi: 10.1002/ijc.2910560115. Int J Cancer. 1994. PMID: 8262682

3

Analysis of T cell receptor alpha beta variability in tumor-infiltrating lymphocytes in primary and metastatic melanoma.

Zeuthen J, Birck A, Straten PT. Zeuthen J, et al. Arch Immunol Ther Exp (Warsz). 1995;43(2):123-33. Arch Immunol Ther Exp (Warsz). 1995. PMID: 8744727

4

Gastrin releasing peptide GRP(14-27) in human breast cancer cells and in small cell lung cancer.

Vangsted AJ, Andersen EV, Nedergaard L, Zeuthen J. Vangsted AJ, et al. Among authors: zeuthen j. Breast Cancer Res Treat. 1991 Oct;19(2):119-28. doi: 10.1007/BF01980942. Breast Cancer Res Treat. 1991. PMID: 1661625

5

Analysis of T cell receptor alpha beta variability in lymphocytes infiltrating melanoma primary tumours and metastatic lesions.

Schøller J, thor Straten P, Birck A, Siim E, Dahlström K, Drzewiecki KT, Zeuthen J. Schøller J, et al. Among authors: zeuthen j. Cancer Immunol Immunother. 1994 Oct;39(4):239-48. doi: 10.1007/BF01525987. Cancer Immunol Immunother. 1994. PMID: 7954526 Free PMC article.

6

Preferential usage of T-cell receptor alpha beta variable regions among tumor-infiltrating lymphocytes in primary human malignant melanomas.

Thor Straten P, Schøller J, Hou-Jensen K, Zeuthen J. Thor Straten P, et al. Among authors: zeuthen j. Int J Cancer. 1994 Apr 1;57(1):138. doi: 10.1002/ijc.2910570126. Int J Cancer. 1994. PMID: 8150534 No abstract available.

7

Activation of preexisting T cell clones by targeted interleukin 2 therapy.

Straten PT, Guldberg P, Seremet T, Reisfeld RA, Zeuthen J, Becker JC. Straten PT, et al. Among authors: zeuthen j. Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8785-90. doi: 10.1073/pnas.95.15.8785. Proc Natl Acad Sci U S A. 1998. PMID: 9671756 Free PMC article.

8

New serum markers for small-cell lung cancer. I. The ganglioside fucosyl-GM1.

Vangsted A, Drivsholm L, Andersen E, Pallesen T, Zeuthen J, Wallin H. Vangsted A, et al. Among authors: zeuthen j. Cancer Detect Prev. 1994;18(3):221-9. Cancer Detect Prev. 1994. PMID: 8076384

9

T-cell receptor clonotype mapping using denaturing gradient gel electrophoresis : analysis of clonal T-cell responses in melanoma.

Straten PT, Becker JC, Zeuthen J, Guldberg P. Straten PT, et al. Among authors: zeuthen j. Methods Mol Med. 2001;61:339-51. doi: 10.1385/1-59259-145-0:339. Methods Mol Med. 2001. PMID: 22323267

10

Aberrant p27Kip1 promoter methylation in malignant melanoma.

Worm J, Bartkova J, Kirkin AF, Straten P, Zeuthen J, Bartek J, Guldberg P. Worm J, et al. Among authors: zeuthen j. Oncogene. 2000 Oct 19;19(44):5111-5. doi: 10.1038/sj.onc.1203891. Oncogene. 2000. PMID: 11042700

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

181 results

Search Page

Filters